The lung cancer therapeutics market is witnessing rapid advancements in targeted therapies, immuno-oncology, and personalized medicine. Increasing prevalence of lung cancer and growing investments in biotechnology are fueling significant market growth.
Get a full overview of market dynamics, forecasts, and trends. Download the complete Display Market...
"Global Demand Outlook for Executive Summary Non-Small Cell Lung Cancer Market Size and Share
CAGR Value
Data Bridge Market Research analyses that the non-small cell lung cancer market which is USD 26948.36 million in 2022, is expected to reach USD 76334.72 million by 2030, at a CAGR of 13.9% during the forecast period 2023 to 2030.
For a constantly increasing business growth and maximum return...